Investment Analysts’ updated eps estimates for Thursday, May 9th:
Compass (NYSE:COMP) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $5.00 target price on the stock.
CRISPR Therapeutics (NASDAQ:CRSP) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $86.00 target price on the stock.
IonQ (NYSE:IONQ) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $18.00 price target on the stock.
Legend Biotech (NASDAQ:LEGN) had its buy rating reissued by analysts at HC Wainwright. They currently have a $87.00 price target on the stock.
Montrose Environmental Group (NYSE:MEG) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $54.00 target price on the stock.
PDS Biotechnology (NASDAQ:PDSB) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $21.00 target price on the stock.
Protagonist Therapeutics (NASDAQ:PTGX) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $38.00 price target on the stock.
Cartesian Therapeutics (NASDAQ:RNAC) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $54.00 target price on the stock.
Sana Biotechnology (NASDAQ:SANA) had its buy rating reissued by analysts at HC Wainwright. They currently have a $12.00 price target on the stock.
Super Group (NYSE:SGHC) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $6.00 price target on the stock.
STERIS (NYSE:STE) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $265.00 price target on the stock.
Verve Therapeutics (NASDAQ:VERV) had its buy rating reissued by analysts at HC Wainwright. They currently have a $15.00 price target on the stock.
Receive News & Ratings for Compass Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compass Inc and related companies with MarketBeat.com's FREE daily email newsletter.
